China Menopause Market Size & Outlook, 2024-2030

The menopause market in China is expected to reach a projected revenue of US$ 3,695.4 million by 2030. A compound annual growth rate of 4.7% is expected of China menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$2,773.8
Forecast, 2030 (US$M)
$3,695.4
CAGR, 2025 - 2030
4.7%
Report Coverage
China

China menopause market highlights

  • The China menopause market generated a revenue of USD 2,502.2 million in 2022 and is expected to reach USD 3,695.4 million by 2030.
  • The China market is expected to grow at a CAGR of 5% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • OTC pharma products is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 2,502.2 million
Market revenue in 2030USD 3,695.4 million
Growth rate5% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentOTC pharma products
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, China accounted for 15.5% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China menopause market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,632.2 million by 2030.

Dietary supplements was the largest segment with a revenue share of 98.49% in 2024. Horizon Databook has segmented the China menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


The country is witnessing key product innovations by key players, focused on using natural sources for obtaining dietary supplements. In February 2020, a biopharmaceutical company, the Zhilin Group, launched a dietary supplement obtained from extracted yam powder for use by menopausal women. Nativus Life Sciences Limited, a subsidiary of Zhilin Group, has made a regional distribution agreement with Wantian Tea Company Limited to promote the product to a wider customer pool.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

China menopause market size, by treatment, 2018-2030 (US$M)

China Menopause Market Outlook Share, 2024 & 2030 (US$M)

China menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more